Cho H - Search Results

1

Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models.

Shin HY, Lee EJ, Yang W, Kim HS, Chung D, Cho H, Kim JH. Shin HY, et al. Among authors: cho h. Cancers (Basel). 2022 Feb 6;14(3):829. doi: 10.3390/cancers14030829. Cancers (Basel). 2022. PMID: 35159096 Free PMC article.

2

Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.

Cho H, Kang ES, Hong SW, Oh YJ, Choi SM, Kim SW, Kim SH, Kim YT, Lee KS, Choi YK, Kim JH. Cho H, et al. Mol Cell Biochem. 2008 Dec;319(1-2):189-201. doi: 10.1007/s11010-008-9892-4. Epub 2008 Aug 6. Mol Cell Biochem. 2008. PMID: 18682896

3

Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer.

Cho H, Kim JH. Cho H, et al. J Histochem Cytochem. 2009 May;57(5):513-21. doi: 10.1369/jhc.2009.953257. Epub 2009 Feb 2. J Histochem Cytochem. 2009. PMID: 19188485 Free PMC article.

4

Diagnostic and prognostic impact of osteopontin expression in endometrial cancer.

Cho H, Kang ES, Kim YT, Kim JH. Cho H, et al. Cancer Invest. 2009 Mar;27(3):313-23. doi: 10.1080/07357900802375738. Cancer Invest. 2009. PMID: 19194826

5

Multiplication of neutrophil and monocyte counts (MNM) as an easily obtainable tumour marker for cervical cancer.

Cho H, Kim JH. Cho H, et al. Biomarkers. 2009 May;14(3):161-70. doi: 10.1080/13547500902777616. Biomarkers. 2009. PMID: 19399661

6

Molecular characterization of a new ovarian cancer cell line, YDOV-151, established from mucinous cystadenocarcinoma.

Cho H, Lim BJ, Kang ES, Choi JS, Kim JH. Cho H, et al. Tohoku J Exp Med. 2009 Jun;218(2):129-39. doi: 10.1620/tjem.218.129. Tohoku J Exp Med. 2009. PMID: 19478469 Free article.

7

Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study.

Cho H, Kim MK, Lee JK, Son SK, Lee KB, Lee JM, Lee JP, Hur SY, Kim JH. Cho H, et al. Clin Chem Lab Med. 2009;47(8):1005-12. doi: 10.1515/CCLM.2009.221. Clin Chem Lab Med. 2009. PMID: 19589102

8

Treatment of the patients with abnormal cervical cytology: a "see-and-treat" versus three-step strategy.

Cho H, Kim JH. Cho H, et al. J Gynecol Oncol. 2009 Sep;20(3):164-8. doi: 10.3802/jgo.2009.20.3.164. Epub 2009 Sep 30. J Gynecol Oncol. 2009. PMID: 19809550 Free PMC article.

9

Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy.

Cho H, Kim YT, Kim JH. Cho H, et al. Acta Obstet Gynecol Scand. 2010;89(2):175-81. doi: 10.3109/00016340903418785. Acta Obstet Gynecol Scand. 2010. PMID: 19943822 Free article.

10

Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.

Kim S, Cho H, Nam EJ, Kim SW, Kim YT, Park YW, Kim BW, Kim JH. Kim S, et al. Among authors: cho h. Genes Chromosomes Cancer. 2010 Jul;49(7):585-95. doi: 10.1002/gcc.20769. Genes Chromosomes Cancer. 2010. PMID: 20461751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,926 results

Search Page

Filters